Zinc supplementation and the effects on metabolic status in gestational diabetes: A randomized, double-blind, placebo-controlled trial

被引:44
作者
Karamali, Maryam [1 ,2 ]
Heidarzadeh, Zahra [3 ]
Seifati, Seyed Morteza [3 ]
Samimi, Mansooreh [4 ]
Tabassi, Zohreh [4 ]
Hajijafari, Mohammad [5 ]
Asemi, Zatollah [5 ]
Esmaillzadeh, Ahmad [6 ,7 ]
机构
[1] Arak Univ Med Sci, Dept Gynecol & Obstet, Sch Med, Arak, Iran
[2] Iran Univ Med Sci, Dept Gynecol & Obstet, Sch Med, Tehran, Iran
[3] Islamic Azad Univ, Dept Biol, Ashkezar, Iran
[4] Kashan Univ Med Sci, Dept Gynecol & Obstet, Sch Med, Kashan, Iran
[5] Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran
[6] Isfahan Univ Med Sci, Food Secur Res Ctr, Esfahan, Iran
[7] Isfahan Univ Med Sci, Dept Community Nutr, Sch Nutr & Food Sci, Esfahan, Iran
关键词
Zinc; Supplementation; Insulin metabolism; Lipid concentrations; Gestational diabetes; OXIDATIVE STRESS; INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; GLYCEMIC CONTROL; HYPERTENSION; LIPOPROTEINS; INFLAMMATION; RESISTANCE; PREGNANCY; CHILDREN;
D O I
10.1016/j.jdiacomp.2015.07.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To the best of our knowledge, no reports are available indicating the effects of zinc supplementation on metabolic status in women with gestational diabetes (GDM). This study was designed to determine the effects of zinc supplementation on glucose homeostasis parameters and lipid concentrations in GDM women. Methods: This randomized, double-blind, placebo-controlled trial was performed among 58 women diagnosed with GDM, primigravida and aged 18-40 years old. Patients were randomly divided into two groups to receive 233 mg zinc gluconate (containing 30 mg zinc) supplements (n = 29) or placebo (n = 29) per day for 6 weeks. Fasting blood samples were taken at the beginning and end of the trial to quantify glucose, insulin and lipid concentrations. Results: Patients who received zinc supplements had significantly higher serum zinc concentrations (+ 6.9 13.2 vs. -1.5 +/- 16.5 mg/dL, P = 0.03) than those received the placebo. In addition, zinc-supplemented patients had reduced fasting plasma glucose (FPG) (-6.6 +/- 11.2 vs. + 0.6 +/- 6.7 mg/dL, P = 0.005), serum insulin levels (-1.3 +/- 6.6 vs. + 6.6 +/- 12.2 mu IU/mL, P = 0.003), homeostasis model of assessment-insulin resistance (HOMA-IR) (-0.5 +/- 1.6 vs. +1.5 +/- 2.7, P = 0.001), homeostatic model assessment-Beta cell function (HOMA-B) (-0.7 +/- 25.0 vs. + 26.5 +/- 49.5, P = 0.01) and increased quantitative insulin sensitivity check index (QUICKI) ( + 0.01 0.01 vs. -0.01 +/- 0.02, P = 0.004) compared with the placebo. Additionally, significant differences in serum triglycerides (+ 13.6 +/- 61.4 vs. +45.9 +/- 36.5 mg/dL, P = 0.01) and VLDL-cholesterol concentrations (+2.7 +/- 12.3 vs. +9.2 +/- 7.3 mg/dL, P = 0.01) were observed following the administration of zinc supplements compared with the placebo. We did not observe any significant effects of taking zinc supplements on other lipid profiles. Conclusions: Taken together, 30 mg zinc supplementation per day for 6 weeks among GDM women had beneficial effects on metabolic profiles. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:1314 / 1319
页数:6
相关论文
共 33 条
  • [1] Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
  • [2] Effects of calcium-vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial (Publication with Expression of Concern)
    Asemi, Zatollah
    Karamali, Maryam
    Esmaillzadeh, Ahmad
    [J]. DIABETOLOGIA, 2014, 57 (09) : 1798 - 1806
  • [3] Favourable effects of the Dietary Approaches to Stop Hypertension diet on glucose tolerance and lipid profiles in gestational diabetes: a randomised clinical trial (Publication with Expression of Concern. See vol. 127, pg. 151, 2022)
    Asemi, Zatollah
    Tabassi, Zohreh
    Samimi, Mansooreh
    Fahiminejad, Taherh
    Esmaillzadeh, Ahmad
    [J]. BRITISH JOURNAL OF NUTRITION, 2013, 109 (11) : 2024 - 2030
  • [4] Screening and management of gestational diabetes
    Benhalima, Katrien
    Devlieger, Roland
    Van Assche, Andre
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2015, 29 (03) : 339 - 349
  • [5] Adipocytokines in Normal and Complicated Pregnancies
    Briana, Despina D.
    Malamitsi-Puchner, Ariadne
    [J]. REPRODUCTIVE SCIENCES, 2009, 16 (10) : 921 - 937
  • [6] Zinc and glycemic control: A meta-analysis of randomised placebo controlled supplementation trials in humans
    Capdor, Jasmine
    Foster, Meika
    Petocz, Peter
    Samman, Samir
    [J]. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2013, 27 (02) : 137 - 142
  • [7] Zinc, insulin and diabetes
    Chausmer, AB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 1998, 17 (02) : 109 - 115
  • [8] Dietary Interventions, Lifestyle Changes, and Dietary Supplements in Preventing Gestational Diabetes Mellitus: A Literature Review
    Facchinetti, Fabio
    Dante, Giulia
    Petrella, Elisabetta
    Neri, Isabella
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2014, 69 (11) : 669 - 680
  • [9] Is There Evidence of Separate Inflammatory or Metabolic Forms of Preeclampsia?
    Founds, Sandra A.
    Catov, Janet M.
    Gallaher, Marcia J.
    Harger, Gail F.
    Markovic, Nina
    Roberts, James M.
    [J]. HYPERTENSION IN PREGNANCY, 2011, 30 (01) : 1 - 10
  • [10] Garg V K, 1994, J Assoc Physicians India, V42, P720